Sufenta (sufentanil recalls

The FDA has published 1 recall involving Sufenta (sufentanil since 2023. The latest was reported on 7 Jun 2023. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2023

Last 12 months0reported

Class I00% of total

Ongoing1latest 7 Jun 2023

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why sufenta (sufentanil is recalled

Potency & Assay1100%

Companies

Akorn1100%

By year

20231100%

Ongoing sufenta (sufentanil recalls

1 active

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Sufenta (Sufentanil Citrate Injection, USP) 50 mcg/mL recalled by Akorn	Akorn	Potency & Assay	Nationwide

All sufenta (sufentanil recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Sufenta (Sufentanil Citrate Injection, USP) 50 mcg/mL recalled by Akorn	Akorn	Potency & Assay	Nationwide

Should you stop taking Sufenta (sufentanil?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.